Our findings provide evidence that 2,5-DHBA ameliorates lipid accumulation in hepatocytes and in HFD-induced MASLD mice, likely through the modulation of the CCL2-CCR2 axis. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.